Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.53 |
| ▸ | FNTB | P49356 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 15/20 | 0.52 |
| ▸ | CA2 | P00918 | 15/20 | 0.52 |
| ▸ | CA9 | Q16790 | 14/20 | 0.52 |
| ▸ | CA12 | O43570 | 5/20 | 0.52 |
| ▸ | CA7 | P43166 | 5/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.52 |
| ▸ | CA3 | P07451 | 4/20 | 0.52 |
| ▸ | CA4 | P22748 | 4/20 | 0.52 |
| ▸ | CA6 | P23280 | 4/20 | 0.52 |
| ▸ | CA5A | P35218 | 4/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27576132 | 1.00 | FNTA (0.53) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL1712192 | 1.00 | FNTA (0.53) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL5788200 | 1.00 | FNTA (0.53) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL17456410 | 0.97 | FNTA (0.52) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL17456490 | 0.97 | FNTA (0.52) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL3640927 | 0.97 | CA2 (0.50) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL17456416 | 0.94 | FNTA (0.48) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL923333 | 0.90 | FNTA (0.45) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL11587906 | 0.89 | FNTA (0.47) | FNTAFNTBCA1CA2CA9 | |
| SCHEMBL6049745 | 0.89 | FNTA (0.47) | FNTAFNTBCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3458560-A1 | DETERGENT COMPOSITION COMPRISING ENCAPSULATES | The Procter and Gamble Company (US) | 2019-03-27 | — | — | EP | disclosed |
| US-20180216030-A1 | CONCENTRATED SURFACTANT COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2018-08-02 | — | — | US | disclosed |
| US-20180216029-A1 | CONCENTRATED SURFACTANT COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2018-08-02 | — | — | US | disclosed |
| WO-2018140674-A1 | CONCENTRATED SURFACTANT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2018-08-02 | — | — | WO | disclosed |
| WO-2018140673-A1 | CONCENTRATED SURFACTANT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2018-08-02 | — | — | WO | disclosed |
| WO-2018140672-A1 | CONCENTRATED SURFACTANT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2018-08-02 | — | — | WO | disclosed |
| US-20170335246-A1 | DETERGENT COMPOSITION COMPRISING ENCAPSULATES | THE PROCTER & GAMBLE COMPANY | 2017-11-23 | — | — | US | disclosed |
| WO-2017201114-A1 | DETERGENT COMPOSITION COMPRISING ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-23 | — | — | WO | disclosed |
| EP-3191570-A2 | DETERGENT COMPOSITIONS CONTAINING A BRANCHED SURFACTANT | The Procter and Gamble Company (US) | 2017-07-19 | — | — | EP | disclosed |
| US-9493725-B2 | Detergent compositions containing a predominantly C15 alkyl branched surfactant | THE PROCTER & GAMBLE COMPANY (US) | 2016-11-15 | — | — | US | disclosed |
| US-8586015-B2 | Compositions comprising surfactants and glycerol-modified silicones | THE PROCTER & GAMBLE COMPANY (US) | 2013-11-19 | — | — | US | disclosed |
| US-8440174-B2 | Compositions comprising surfactants and alkyloxy-modified silicone | THE PROCTER & GAMBLE COMPANY (US) | 2013-05-14 | — | — | US | disclosed |
| EP-2552400-A1 | COMPOSITION COMPRISING MODIFIED ORGANOSILICONES | The Procter & Gamble Company (US) | 2013-02-06 | — | — | EP | disclosed |
| EP-2553078-A1 | COMPOSITIONS COMPRISING ORGANOSILICONES | The Procter & Gamble Company (US) | 2013-02-06 | — | — | EP | disclosed |
| US-20120052038-A1 | Organosilicones | THE PROCTER & GAMBLE COMPANY | 2012-03-01 | — | — | US | disclosed |
| WO-2011141497-A1 | COMPOSITIONS COMPRISING CARE POLYMERS | BASF SE (DE) | 2011-11-17 | — | — | WO | disclosed |
| WO-2011123732-A1 | COMPOSITION COMPRISING MODIFIED ORGANOSILICONES | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-06 | — | — | WO | disclosed |
| WO-2011123739-A1 | COMPOSITIONS COMPRISING ORGANOSILICONES | THE PROCTER & GAMBLE COMPANY (US) | 2011-10-06 | — | — | WO | disclosed |
| US-20110243871-A1 | ORGANOSILICONES | THE PROCTER & GAMBLE COMPANY | 2011-10-06 | — | — | US | disclosed |
| US-20110243875-A1 | CARE POLYMERS | THE PROCTER & GAMBLE COMPANY | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052038-A1 | Organosilicones | NISCH, XRCC6, RAD50 | FNTA 1098/4885FNTB 3737/4885CA1 3544/4885 |
| US-20110243871-A1 | ORGANOSILICONES | NISCH, XRCC6, RAD50 | FNTA 1098/4885FNTB 3737/4885CA1 3544/4885 |
| US-20110243875-A1 | CARE POLYMERS | SMURF1, PUF60, PCBP1 | FNTA 3290/4885FNTB 3810/4885CA1 3923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.